SRx Health Solutions Inc. has entered into a Securities Purchase Agreement with accredited investors for a private placement of up to 38,070 shares of its Series A convertible preferred stock and accompanying warrants to purchase common stock, for a total potential raise of $30.46 million. In the initial closing, the company issued 19,035 shares of Series A preferred stock and 54,527,811 warrants, raising approximately $15.23 million through cash payments or the cancellation of certain prior notes and warrants. The warrants have a three-year term with an initial exercise price of $0.6109, subject to adjustment under specific conditions. Additional closings may occur at the option of the investors, pending customary closing conditions.